Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
March 04, 2020 16:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., March 04, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...
Avid Bioservices to Report Financial Results for Third Quarter of Fiscal Year 2020 After Market Close on March 10, 2020
March 03, 2020 16:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., March 03, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...
Avid Bioservices Appoints Timothy Compton as Chief Commercial Officer
January 08, 2020 08:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Jan. 08, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...
Avid Bioservices Reports Financial Results for Second Quarter Fiscal 2020 and Recent Developments
December 09, 2019 16:05 ET
|
Avid Bioservices, Inc
-- Achieved Strong Second Quarter Revenue of $18.3 Million and Gross Margin of 18% -- -- Fiscal 2020 Projected Revenue of $64 to $67 Million Reaffirmed -- -- Launched Expanded Process Development...
Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
December 04, 2019 16:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Dec. 04, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...
Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2020 After Market Close on December 9, 2019
December 02, 2019 08:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Dec. 02, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...
Medical Device Outsourcing Market To Reach USD 208.36 Billion By 2026 | Reports And Data
November 20, 2019 15:22 ET
|
Reports and Data
New York, Nov. 20, 2019 (GLOBE NEWSWIRE) -- Increasing demand for medical devices combined with rising price competition and the requirement to reduce cost, high prevalence of chronic disorders,...
Particle Sciences becomes Lubrizol Life Science Health
November 05, 2019 10:30 ET
|
Lubrizol
BETHLEHEM, Pa., Nov. 05, 2019 (GLOBE NEWSWIRE) -- The Lubrizol Corporation has announced that its contract development and manufacturing organization (CDMO), Particle Sciences, is to be renamed...
Cytovance® Biologics Introduces an Integrated Single-use Platform for Plasmid DNA (pDNA) Manufacture
October 21, 2019 12:00 ET
|
Cytovance Biologics
OKLAHOMA CITY, Oct. 21, 2019 (GLOBE NEWSWIRE) -- Cytovance Biologics is a leading biopharmaceutical CDMO with a 15-year track record of supplying drug substance to clients, offering fast and...
Hearthside Food Solutions Announces Appointment of Chuck Metzger as CEO
October 17, 2019 09:30 ET
|
Hearthside Food Solutions
DOWNERS GROVE, Ill., Oct. 17, 2019 (GLOBE NEWSWIRE) -- Hearthside Food Solutions (“Hearthside”), a leading contract manufacturer and the largest private bakery in the US, announced today the...